Transcriptomics and Metabolomics Identify Drug Resistance of Dormant Cell in Colorectal Cancer

Background: Tumor dormancy is an important way to develop drug resistance. This study aimed to identify the characteristics of colorectal cancer (CRC) cell dormancy. Methods: Based on the CRC cohorts, a total of 1,044 CRC patients were included in this study, and divided into a dormant subgroup and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Lang, Huang, Renli, Huang, Hongyun, Liu, Xiaoxia, Yu, Jinlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024109/
https://www.ncbi.nlm.nih.gov/pubmed/35462906
http://dx.doi.org/10.3389/fphar.2022.879751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024109/
https://www.ncbi.nlm.nih.gov/pubmed/35462906
http://dx.doi.org/10.3389/fphar.2022.879751

Ejemplares similares